Emetrol is a medication that is used to treat nausea and vomiting. It is typically used in the first trimester of pregnancy. Emetrol has also been found to be effective in the treatment of postoperative nausea and vomiting. The mechanism of action of Emetrol is not fully understood, but it is thought to work by depressing the central nervous system. Emetrol is available over-the-counter and does not require a prescription.
Emetrol is generally well tolerated. The most common side effect is drowsiness. Other side effects include dry mouth, dizziness, and headache. Emetrol should not be used in people with liver disease or kidney disease . Emetrol is not recommended for use in children under the age of 12.
Emetrol is a safe and effective medication for the treatment of nausea and vomiting. It is important to talk to your doctor if you are pregnant or breastfeeding before taking Emetrol.
Benefits of Emetrol
- Relieves nausea and vomiting
- Can be used during pregnancy
- Safe for children
- Does not require a prescription
- Side effects of Emetrol
- Dry mouth
Pharmacokinetics of Emetrol
Emetrol is rapidly absorbed from the gastrointestinal tract and undergoes first-pass metabolism in the liver. The bioavailability of Emetrol is unknown. Emetrol has a half-life of 2-4 hours.
Emetrol is not metabolized by cytochrome P450 enzymes. Emetrol is excreted in urine and feces.
Dosage and Administration of Emetrol
Emetrol is available as a tablet and syrup. The recommended dose for adults and children over the age of 12 is 30-60 mL (1-2 tablespoons) every 4-6 hours as needed.
Emetrol should be taken with food or milk to decrease the risk of gastrointestinal side effects.
Emetrol is not recommended for use in children under the age of 12.
Drug Interactions of Emetrol
Emetrol is not metabolized by cytochrome P450 enzymes and does not interact with other medications. Emetrol may increase the effects of alcohol.
If you are taking any other medications, it is important to talk to your doctor before taking Emetrol.
Pregnancy and Lactation of Emetrol
Emetrol is classified as pregnancy category B by the FDA. Animal studies have shown no evidence of teratogenicity, but there are no adequate and well-controlled studies in pregnant women.
Emetrol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is not known if Emetrol is excreted in breast milk. Emetrol should be used with caution in breastfeeding women.